Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

1.735 +0.035 (+2.06%)
Streaming Delayed Price Updated: 10:02 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
MIRA Pharmaceuticals stock is up on Monday after the company posted results from a pre-clinical trial of its novel oral ketamine analog. 
Via InvestorPlace
RDDT Stock Alert: Reddit Nabs New Deals with NFL, NBA
Reddit stock is up on Monday after investors in RDDT learned of the company signing new deals with sports leagues for content. 
Via InvestorPlace
SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
Cassava Sciences stock is up on Monday after the company provided SAVA investors with an update on its upcoming clinical trial data. 
Via InvestorPlace
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Cassava Sciences Stock Is Skyrocketing Today
Investors liked what Cassava's new executive chairman had to say. 
Via The Motley Fool
Peering Into Cassava Sciences's Recent Short Interest
Via Benzinga
Dow Jumps 200 Points; Synchrony Financial Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Cassava Sciences stock is down on high trading volume following leadership changes. Richard Barry is appointed as Executive Chairman and interim CEO, succeeding Remi Barbier. SVP Lindsay Burns also... 
Via Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
SOUN Stock: Sports Bar Chain Rolls Out Voice Tech From SoundHound AI
SoundHound AI stock is down on Wednesday even as SOUN investors learn of a new collaboration with sports bar chain Beef 'O' Brady's. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
The CEO of Cassava Sciences is stepping down, effective immediately. Here's what this means for troubled SAVA stock. 
Via InvestorPlace
Crude Oil Rises 2%; Five Below Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates
Via Benzinga
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell. 
Via InvestorPlace
Top 5 Health Care Stocks That May Explode In July
Via Benzinga
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Cassava Sciences Stock Is Sinking Today
The biotech stock is feeling the heat from an indictment of a former consultant. 
Via The Motley Fool
Planet Labs Layoffs 2024: What to Know About the Latest Planet Job Cuts
Planet Labs layoffs are a hot topic on Monday as the satellite company prepares to cut 180 jobs, or 17% of its workforce, to reduce costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Cassava Sciences is cooperating with DOJ and SEC investigations involving its Alzheimer's drug simufilam. An internal committee is examining new SEC information, while the company advances its Phase 3... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Are Stocks Down Today?
Stocks are down today and investors wondering why have come to the right place as we know what's sending shares lower on Monday! 
Via InvestorPlace
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
SAVA stock is trading lower after a scientist behind Cassava's simufilam was charged with manipulating research data to justify his grants. 
Via InvestorPlace
Cassava Shares Are Down Over 30%: Here's Why
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading significantly lower on Friday following the indictment of Hoau-Yan Wang, a tenured medical professor and advisor to the company, by a federal... 
Via Benzinga
Cassava Sciences Issues Statement on Former Science Advisor
From Cassava Sciences, Inc.
Via GlobeNewswire
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024
SAVA stock results show that Cassava Sciences beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.